Are you Dr. Presti?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
275 W MacArthur Blvd
Oakland, CA 94611Phone+1 510-752-1000Fax+1 650-723-0765
Summary
- Dr. Joseph Presti Jr., MD is a board certified urologist in Oakland, California. He is currently licensed to practice medicine in California. He is affiliated with Kaiser Permanente Oakland Medical Center and Stanford Health Care.
Education & Training
- University of California (San Francisco)Residency, Urology, 1986 - 1989
- University of California (San Francisco) School of MedicineInternship, Transitional Year, 1984 - 1985
- University of California, Irvine, School of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 1986 - 2025
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 48 citationsPROSTATE CANCER: ASSESSMENT OF RISK USING DIGITAL RECTAL EXAMINATION, TUMOR GRADE, PROSTATE-SPECIFIC ANTIGEN, AND SYSTEMATIC BIOPSYJoseph C. Presti
Radiologic Clinics of North America. 2000-01-01 - 69 citationsProstate biopsy: how many cores are enough?Joseph C. Presti
Urologic Oncology. 2003-03-01 - 344 citationsTHE OPTIMAL SYSTEMATIC PROSTATE BIOPSY SCHEME SHOULD INCLUDE 8 RATHER THAN 6 BIOPSIES: RESULTS OF A PROSPECTIVE CLINICAL TRIALJoseph C. Presti, James J. Chang, Vivek Bhargava, Katsuto Shinohara
The Journal of Urology. 2000-01-01
Press Mentions
- With Help from Kaiser Permanente, Bladder Cancer CuredJune 28th, 2017
- Study Raises Questions About Best Practices in Muscle-Invasive Bladder CancerJuly 26th, 2023
Professional Memberships
- Member